The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Supply Chain Strategies & Solutions Article
Healthcare delivery systems in the U.S. have traditionally targeted health intervention strategies at individuals rather than populations.
Supply Chain Strategies & Solutions Article
Real-time supply chain costs serve as an indicator of how efficiently resources are being used by different parts of the organization.
Webcast
Susan Morris, CMRP, FAHRMM, health care executive, Cerner Corporation, explains the different parts of the Unique Device Identifier (UDI) and
Webcast
Get introduced to risk sharing in health care and learn how providers and suppliers can work together to generate financial, operational and clinic
Webcast
Data visualization can help translate dashboards, benchmarking and metrics lines, and lines of supply chain data into actionable insight.